{
  "CellLine_hpscreg_id": "MCRIi024-A",
  "CellLine_alt_names": [
    "Patient iPSC line - ACTA1.1u (MCRIi024-A)"
  ],
  "CellLine_cell_line_type": "hiPSC",
  "CellLine_source_cell_type": "PBMC",
  "CellLine_publication_doi": "10.1016/j.scr.2021.102429",
  "CellLine_publication_pmid": "",
  "CellLine_publication_title": "Generating an iPSC line (with isogenic control) from the PBMCs of an ACTA1 (p.Gly148Asp) nemaline myopathy patient",
  "CellLine_publication_first_author": "Peter J. Houweling",
  "CellLine_publication_last_author": "Kathryn N. North",
  "CellLine_publication_journal": "Stem Cell Research",
  "CellLine_publication_year": 2021,
  "CellLine_donor_age": 5,
  "CellLine_donor_sex": "Male",
  "CellLine_donor_disease_name": "Nemaline myopathy",
  "CellLine_donor_disease_description": "A heterogeneous group of inherited myopathies caused by mutations in at least 12 different genes, characterized by muscle weakness and hypotonia.",
  "CellLine_source_tissue": "Blood",
  "CellLine_source": "donor",
  "CellLine_contact_name": "Kathryn N. North",
  "CellLine_contact_email": "Kathryn.north@mcri.edu.au",
  "CellLine_contact_phone": "",
  "CellLine_maintainer": "Murdoch Children's Research Institute",
  "CellLine_producer": "Murdoch Children's Research Institute",
  "CellLine_frozen": true,
  "GenomicAlteration_performed": true,
  "GenomicAlteration_mutation_type": "variant",
  "GenomicAlteration_cytoband": "",
  "GenomicAlteration_delivery_method": "transgene expression",
  "GenomicAlteration_loci_name": "ACTA1",
  "GenomicAlteration_loci_chromosome": "",
  "GenomicAlteration_loci_start": 443,
  "GenomicAlteration_loci_end": 443,
  "GenomicAlteration_loci_group": "",
  "GenomicAlteration_loci_disease": "Nemaline myopathy",
  "GenomicAlteration_description": "Heterozygous ACTA1 c.443G>A (p.Gly148Asp) mutation in exon 3 of the ACTA1 gene.",
  "GenomicAlteration_genotype": "Heterozygous",
  "PluripotencyCharacterisation_cell_type": "Endoderm",
  "PluripotencyCharacterisation_shown_potency": true,
  "PluripotencyCharacterisation_marker_list": [
    "OCT4",
    "NANOG",
    "SOX17",
    "PAX6",
    "Nestin",
    "MEOX1",
    "FOXC2",
    "PAX3",
    "PRXX1"
  ],
  "PluripotencyCharacterisation_method": "Immunofluorescent staining and flow cytometry",
  "PluripotencyCharacterisation_differentiation_profile": "in vitro directed differentiation",
  "ReprogrammingMethod_vector_type": "non-integrated",
  "ReprogrammingMethod_vector_name": "episomal reprogramming vectors",
  "ReprogrammingMethod_kit": "",
  "ReprogrammingMethod_detected": true,
  "GenomicCharacterisation_passage_number": 0,
  "GenomicCharacterisation_karyotype": "46, XY",
  "GenomicCharacterisation_karyotype_method": "G-Banding",
  "GenomicCharacterisation_summary": "Genome SNP array analysis confirmed a stable karyotype and SNP Duo analysis confirmed >99.9% identity to the parental line.",
  "STR_Results_exists": false,
  "STR_Results_loci": "",
  "STR_Results_group": "",
  "STR_Results_allele_1": "",
  "STR_Results_allele_2": "",
  "InducedDerivation_i_source_cell_type": "PBMC",
  "InducedDerivation_i_cell_origin": "Blood",
  "InducedDerivation_derivation_year": "2020",
  "InducedDerivation_vector_type": "non-integrated",
  "InducedDerivation_vector_name": "episomal reprogramming vectors",
  "InducedDerivation_kit_name": "",
  "EmbryonicDerivation_embryo_stage": "",
  "EmbryonicDerivation_zp_removal_technique": "",
  "EmbryonicDerivation_cell_seeding": "",
  "EmbryonicDerivation_e_preimplant_genetic_diagnosis": "",
  "Ethics": [
    {
      "ethics_number": "HREC/45380/RCHM-2018-154931",
      "approval_date": "",
      "institutional_HREC": "Royal Children's Hospital"
    },
    {
      "ethics_number": "38192",
      "approval_date": "",
      "institutional_HREC": "Royal Children's Hospital"
    }
  ],
  "MicrobiologyVirologyScreening_performed": true,
  "MicrobiologyVirologyScreening_hiv1": "",
  "MicrobiologyVirologyScreening_hiv2": "",
  "MicrobiologyVirologyScreening_hep_b": "",
  "MicrobiologyVirologyScreening_hep_c": "",
  "MicrobiologyVirologyScreening_mycoplasma": "negative",
  "MicrobiologyVirologyScreening_other": "",
  "MicrobiologyVirologyScreening_other_result": "",
  "CultureMedium_co2_concentration": 5,
  "CultureMedium_o2_concentration": 21,
  "CultureMedium_rho_kinase_sed": "",
  "CultureMedium_passage_method": "Enzyme-free cell dissociation",
  "CultureMedium_other_passage_method": "",
  "CultureMedium_methods_io_id": "",
  "CultureMedium_base_medium": "Essential 8 (E8) medium",
  "CultureMedium_base_coat": "Matrigel",
  "CultureMedium_MediumComponents_medium_component_name": "",
  "CultureMedium_MediumComponents_company": "Thermo Fisher Scientific",
  "CultureMedium_MediumComponents_component_type": ""
}